Panel: Tech transfer & manufacturing readiness for scaling biotech

For emerging biotechs, establishing strong foundations in tech transfer and manufacturing readiness is critical to avoid costly bottlenecks during scale-up. This panel will explore how early-stage decisions impact scalability, quality, and regulatory compliance, with insights from leaders at Tolerance Bio and Caribou Biosciences. 

Key takeaways: 

• Establish robust early-stage processes to streamline tech transfer and scale-up 

• Manage variability, comparability, and regulatory expectations during GMP transitions 

• Apply lessons learned from biotechs on workforce readiness and internal capability building 

• Evaluate CDMO selection strategies and cost considerations for growing companies 

• Identify practical frameworks to align technical operations with long-term growth goals